Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

Open Vet J. 2015; 5(2): 138-147

Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study

A.G. Pose, E.S. Rodríguez, A.C. Méndez, J.N. Gómez, A.V. Redondo, E.R. Rodríguez, E.M.G. Ramos, A.Á. Gutiérrez, M.P.R. Moltó, D.G. Roche, Y.S. Ugalde, A.M. López.

In this study we demonstrated that the vaccine candidate against avian influenza virus H5N1 based on the hemagglutinin H5 (HA) fused to the chicken CD154 (HACD) can also be used for differentiating infected from vaccinated animals (DIVA). As the strategy of DIVA requires at least two proteins, we obtained a variant of the nucleoprotein (NP49-375) in E. coli. After its purification by IMAC, the competence of the proteins NP49-375 and HACD as coating antigens in indirect ELISA assays were tested by using the sera of chickens immunized with the proteins HA and HACD and the reference sera from several avian influenza subtypes. Together with these sera, the sera from different species of birds and the sera of chickens infected with other avian viral diseases were analyzed by competition ELISA assays coated with the proteins NP49-375 and HACD. The results showed that the segment CD154 in the chimeric protein HACD did not interfere with the recognition of the molecule HA by its specific antibodies. Also, we observed variable detection levels when the reference sera were analyzed in the ELISA plates coated with the protein NP49-375. Moreover, only the antibodies of the reference serum subtype H5 were detected in the ELISA plates coated with the protein HACD. The competition ELISA assays showed percentages of inhibition of 88-91% for the positives sera and less than 20% for the negative sera. We fixed the cut-off value of these assays at 25%. No antibody detection was observed in the sera from different species of birds or the sera of chickens infected with other avian viral diseases. This study supported the fact that the ELISA assays using the proteins NP49-375 and HACD could be valuable tools for avian influenza surveillance and as a strategy of DIVA for counteracting the highly pathogenic avian influenza virus H5N1 outbreaks.

Key words: Avian influenza virus, CD154, Competition ELISA, DIVA, Hemagglutinin.

Full-text options

Full-text Article

Share this Article

Readers of this article also read the following articles
»Toxic Chemicals Associated With Milk Powder Consumption
»House Dust Mites from Public Health’s Perspective
»The Psychometric Properties of Turkish Version of Depression Anxiety Stress Scale-21 (DASS-21) in Community and Clinical Samples
»Posttraumatic stress disorder in children after Çubuk Tornado: a one year follow up study
»An epidemiological study of self-medication among urban adults of Aligarh
»Effect of Some Algal Species on the Snail Intermediate Hosts of Schistosomiasis in Egypt II. Growth, Infection and Mortality Rates
»Warfarin Related Nephropathy and Beyond. What Renal Pathologists Need To Suspect in A Kidney Biopsy.
»Treatment of acute and subacute dorsal perilunate fracture dislocations
»Burn Injury Arise From Flying Balloon Toys
»A rare case of locally advanced mucinous adenocarcinoma of the appendix confined in the inguinal canal: Clinical presentation, operative management
»Status of the Community Based Monitoring at Sub Centers in Maharashtra

Journal of Environmental and Occupational Science


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.